122 related articles for article (PubMed ID: 30360368)
1. The Pro-Tumoral Activity of Heparan Sulfate 3-
Hellec C; Diawara M; Carpentier M; Denys A; Allain F
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360368
[TBL] [Abstract][Full Text] [Related]
2. The heparan sulfate 3-O-sulfotransferases (HS3ST) 2, 3B and 4 enhance proliferation and survival in breast cancer MDA-MB-231 cells.
Hellec C; Delos M; Carpentier M; Denys A; Allain F
PLoS One; 2018; 13(3):e0194676. PubMed ID: 29547633
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the Expression of Heparan Sulfate 3-O-Sulfotransferase 3B (HS3ST3B) by Inflammatory Stimuli in Human Monocytes.
Sikora AS; Delos M; Martinez P; Carpentier M; Allain F; Denys A
J Cell Biochem; 2016 Jul; 117(7):1529-42. PubMed ID: 26575945
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate 3-O-sulfotransferase 2 (HS3ST2) displays an unexpected subcellular localization in the plasma membrane.
Delos M; Foulquier F; Hellec C; Vicogne D; Fifre A; Carpentier M; Papy-Garcia D; Allain F; Denys A
Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1644-1655. PubMed ID: 29660372
[TBL] [Abstract][Full Text] [Related]
5. The Emerging Roles of Heparan Sulfate 3-
Denys A; Allain F
Front Oncol; 2019; 9():507. PubMed ID: 31249810
[TBL] [Abstract][Full Text] [Related]
6. HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression.
Vijaya Kumar A; Salem Gassar E; Spillmann D; Stock C; Sen YP; Zhang T; Van Kuppevelt TH; Hülsewig C; Koszlowski EO; Pavao MS; Ibrahim SA; Poeter M; Rescher U; Kiesel L; Koduru S; Yip GW; Götte M
Int J Cancer; 2014 Dec; 135(11):2579-92. PubMed ID: 24752740
[TBL] [Abstract][Full Text] [Related]
7. Expanding the 3-O-Sulfate Proteome--Enhanced Binding of Neuropilin-1 to 3-O-Sulfated Heparan Sulfate Modulates Its Activity.
Thacker BE; Seamen E; Lawrence R; Parker MW; Xu Y; Liu J; Vander Kooi CW; Esko JD
ACS Chem Biol; 2016 Apr; 11(4):971-80. PubMed ID: 26731579
[TBL] [Abstract][Full Text] [Related]
8. The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer.
Mao X; Gauche C; Coughtrie MW; Bui C; Gulberti S; Merhi-Soussi F; Ramalanjaona N; Bertin-Jung I; Diot A; Dumas D; De Freitas Caires N; Thompson AM; Bourdon JC; Ouzzine M; Fournel-Gigleux S
Oncogene; 2016 Sep; 35(38):5043-55. PubMed ID: 27041583
[TBL] [Abstract][Full Text] [Related]
9. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
10. EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase.
Lopes CC; Toma L; Pinhal MA; Porcionatto MA; Sogayar MC; Dietrich CP; Nader HB
Biochimie; 2006 Oct; 88(10):1493-504. PubMed ID: 16793191
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1 (HS3ST3B1) promotes angiogenesis and proliferation by induction of VEGF in acute myeloid leukemia cells.
Zhang L; Song K; Zhou L; Xie Z; Zhou P; Zhao Y; Han Y; Xu X; Li P
J Cell Biochem; 2015 Jun; 116(6):1101-12. PubMed ID: 25536282
[TBL] [Abstract][Full Text] [Related]
12. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
Hu B; Guo P; Bar-Joseph I; Imanishi Y; Jarzynka MJ; Bogler O; Mikkelsen T; Hirose T; Nishikawa R; Cheng SY
Oncogene; 2007 Aug; 26(38):5577-86. PubMed ID: 17369861
[TBL] [Abstract][Full Text] [Related]
13. The Heparan Sulfate Sulfotransferases HS2ST1 and HS3ST2 Are Novel Regulators of Breast Cancer Stem-Cell Properties.
Teixeira FCOB; Vijaya Kumar A; Kumar Katakam S; Cocola C; Pelucchi P; Graf M; Kiesel L; Reinbold R; Pavão MSG; Greve B; Götte M
Front Cell Dev Biol; 2020; 8():559554. PubMed ID: 33102470
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-1-dependent regulation of EGF-receptor signaling.
Rizzolio S; Rabinowicz N; Rainero E; Lanzetti L; Serini G; Norman J; Neufeld G; Tamagnone L
Cancer Res; 2012 Nov; 72(22):5801-11. PubMed ID: 22986738
[TBL] [Abstract][Full Text] [Related]
15. Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate.
Cheung WF; Eriksson I; Kusche-Gullberg M; Lindhal U; Kjellén L
Biochemistry; 1996 Apr; 35(16):5250-6. PubMed ID: 8611511
[TBL] [Abstract][Full Text] [Related]
16. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
17. HS2ST1-dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior.
Vijaya Kumar A; Brézillon S; Untereiner V; Sockalingum GD; Kumar Katakam S; Mohamed HT; Kemper B; Greve B; Mohr B; Ibrahim SA; Goycoolea FM; Kiesel L; Pavão MSG; Motta JM; Götte M
Cancer Sci; 2020 Aug; 111(8):2907-2922. PubMed ID: 32573871
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions.
Vintonenko N; Pelaez-Garavito I; Buteau-Lozano H; Toullec A; Lidereau R; Perret GY; Bieche I; Perrot-Applanat M
Cell Adh Migr; 2011; 5(4):332-43. PubMed ID: 21897119
[TBL] [Abstract][Full Text] [Related]
19. A Novel Physiological Glycosaminoglycan-Deficient Splice Variant of Neuropilin-1 Is Anti-Tumorigenic In Vitro and In Vivo.
Hendricks C; Dubail J; Brohée L; Delforge Y; Colige A; Deroanne C
PLoS One; 2016; 11(10):e0165153. PubMed ID: 27798666
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation.
Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ
Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
